» Articles » PMID: 36947105

Heterozygous OT-I Mice Reveal That Antigen-specific CD8 T Cells Shift from Apoptotic to Necrotic Killers in the Elderly

Overview
Journal Aging Cell
Specialties Cell Biology
Geriatrics
Date 2023 Mar 22
PMID 36947105
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous alterations in CD8 T cells contribute to impaired immune responses in elderly individuals. However, the discrimination between cell-intrinsic dysfunctions and microenvironmental changes is challenging. TCR transgenic OT-I mice are utilized to investigate CD8 T-cell immunity, but their immunodeficient phenotype hampers their use especially in aging. Here, we demonstrate that using a heterozygous OT-I model minimizes the current limitations and provides a valuable tool to assess antigen-specific T-cell responses even at old age. We analyzed phenotypic and functional characteristics of CD8 T cells from OT-I and OT-I mice to prove the applicability of the heterozygous system. Our data reveal that OVA-activated CD8 T cells from adult OT-I mice proliferate, differentiate, and exert cytolytic activity equally to their homozygous counterparts. Moreover, common age-related alterations in CD8 T cells, including naive T-cell deterioration and decreased proliferative capacity, also occur in elderly OT-I mice, indicating the wide range of applications for in vivo and in vitro aging studies. We used the OT-I model to investigate cell-intrinsic alterations affecting the cytotoxic behavior of aged CD8 T cells after antigen-specific in vitro activation. Time-resolved analysis of antigen-directed target cell lysis confirmed previous observations that the cytotoxic capacity of CD8 T cells increases with age. Surprisingly, detailed single cell analysis revealed that transcriptional upregulation of perforin in aged CD8 T cells shifts the mode of target cell death from granzyme-mediated apoptosis to rapid induction of necrosis. This unexpected capability might be beneficial or detrimental for the aging host and requires detailed evaluation.

Citing Articles

Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa.

Kansal V, Kinney B, Schmitt N Head Neck. 2024; 46(5):1056-1062.

PMID: 38445546 PMC: 11003840. DOI: 10.1002/hed.27722.


Heterozygous OT-I mice reveal that antigen-specific CD8 T cells shift from apoptotic to necrotic killers in the elderly.

Zophel D, Kaschek L, Steiner R, Janku S, Chang H, Lis A Aging Cell. 2023; 22(6):e13824.

PMID: 36947105 PMC: 10265152. DOI: 10.1111/acel.13824.

References
1.
Fulop T, Kotb R, Fortin C, Pawelec G, De Angelis F, Larbi A . Potential role of immunosenescence in cancer development. Ann N Y Acad Sci. 2010; 1197:158-65. DOI: 10.1111/j.1749-6632.2009.05370.x. View

2.
Li G, Smithey M, Rudd B, Nikolich-Zugich J . Age-associated alterations in CD8α+ dendritic cells impair CD8 T-cell expansion in response to an intracellular bacterium. Aging Cell. 2012; 11(6):968-77. PMC: 3533767. DOI: 10.1111/j.1474-9726.2012.00867.x. View

3.
Westmeier J, Paniskaki K, Karakose Z, Werner T, Sutter K, Dolff S . Impaired Cytotoxic CD8 T Cell Response in Elderly COVID-19 Patients. mBio. 2020; 11(5). PMC: 7502863. DOI: 10.1128/mBio.02243-20. View

4.
Aggarwal S, Gupta S . Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol. 1998; 160(4):1627-37. View

5.
Knorck A, Schafer G, Alansary D, Richter J, Thurner L, Hoth M . Cytotoxic Efficiency of Human CD8 T Cell Memory Subtypes. Front Immunol. 2022; 13:838484. PMC: 9043813. DOI: 10.3389/fimmu.2022.838484. View